Liz KaneImpactful Strategy
Brenda SnowAuthentic Patient Voice
Joey CohenMedication Adherence
Bud BilanichSuccess Coach
Amy GilesIncreasing Engagement
Paul TheisenPatient Acquisition
Matthew DurhamOmnidynamic Marketing
Daniel SontupeMarket Access
Suma Ramadas, PhDMedical Affairs
Matt TurnerPatient Affordability
David LinetskyPoint-of-Care Marketing
Stacey GandlerBrand Nourishment
Pat PurcellMeeting Engagement
Frank BurrellScientific Storytelling
TYME’s novel metabolic-based investigational cancer therapy, SM-88, demonstrated encouraging results and a well-tolerated safety ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email